Rheumatology:急性痛风发作时SUA水平下降原因与全身炎症反应相关

2013-05-03 Rheumatology 丁香园

血清尿酸(SUA)水平在急性痛风发作时下降的原因尚不明确。有观点认为SUA水平的下降与全身炎症反应(SIR)相关,因SIR可促进尿尿酸的排泄。同时亦有观点认为,急性痛风发作时SUA的下降是由痛风病情本身引起的。针对以上分歧,来自英国伍尔弗汉普顿大学临床化学系的Jenna L. Waldron等人进行了一项前瞻性研究,研究结果发表于2013年4月的《风湿病学》(Rheumatology)杂志上。研究

血清尿酸(SUA)水平在急性痛风发作时下降的原因尚不明确。有观点认为SUA水平的下降与全身炎症反应(SIR)相关,因SIR可促进尿尿酸的排泄。同时亦有观点认为,急性痛风发作时SUA的下降是由痛风病情本身引起的。针对以上分歧,来自英国伍尔弗汉普顿大学临床化学系的Jenna L. Waldron等人进行了一项前瞻性研究,研究结果发表于2013年4月的《风湿病学》(Rheumatology)杂志上。研究认为,急性痛风发作时SUA水平下降原因与全身炎症反应相关。

研究纳入了30例行择期膝关节或髋关节手术的患者,评估了各自术前及术后48h的SUA和尿尿酸(UA)排泄数据(尿酸排泄分数;FEua%)。SIR病情通过术前及术后的平均血清CRP和尿微量白蛋白排泄率[白蛋白-肌酐比(ACR)]进行评估。

纳入病例的术后平均(标准差)血清CRP水平较术前明显增加[5.0(5.5)vs 116.0(81.2)mg/l;P<0.0001],尿ACR也表现出相似的改变[0.85(1.03)vs 2.10(2.60)mg/mmol;P=0.004]。SUA水平在术后明显降低[312(64)vs 282(82)umol/l;P=0.0033],但FEua%并无改变[6.4(2.3)vs 7.3(3.3)%;P=0.1726]。

在血尿酸水平正常且无痛风病史的患者中,SIR与SUA水平的降低间存在相关性。SUA水平的下降并非由UA经尿排泄增加所引起。本研究结果支持SUA水平在急性痛风发作时的下降是由机体的SIR病情引起这一观点,其水平下降并非来自痛风本身的影响。

痛风相关的拓展阅读:


The effect of the systemic inflammatory response, as provoked by elective orthopaedic surgery, on serum uric acid in patients without gout: a prospective study.
OBJECTIVE
Acute gout is associated with a decrease in serum uric acid (SUA) that is considered to be in response to acute inflammation but it may be a feature of gout itself. We, therefore, aimed to investigate the effect of the acute systemic inflammatory response (SIR) on SUA concentrations in subjects without gout.
METHODS
SUA and urinary excretion of uric acid (UA) (expressed as fractional excretion of UA; FEua%) were measured in 30 patients before and 48 h after elective knee or hip surgery. The SIR was assessed by measuring serum CRP and urine microalbumin excretion [expressed as the albumin-creatinine ratio (ACR)] before and after surgery in the same patients.
RESULTS
The mean (s.d.) serum CRP increased following surgery [5.0 (5.5) vs 116.0 (81.2) mg/l; P < 0.0001) as did urine ACR [0.85 (1.03) vs 2.10 (2.60) mg/mmol; P = 0.004]. SUA decreased following surgery [312 (64) vs 282 (82) µmol/l; P = 0.0033] but FEua% was unchanged [6.4 (2.3) vs 7.3 (3.3)%; P = 0.1726].
CONCLUSION
The SIR is associated with a decrease in SUA concentrations in normouricaemic patients without gout. The decrease in SUA concentrations is not due to increased urinary excretion of UA. This study supports the notion that the decrease in SUA during acute gout is due to the associated SIR rather than gout per se.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1655031, encodeId=9edb1655031fb, content=<a href='/topic/show?id=7b07e1166af' target=_blank style='color:#2F92EE;'>#痛风发作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71166, encryptionId=7b07e1166af, topicName=痛风发作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfb924615150, createdName=楚秀娟, createdTime=Tue May 21 02:09:00 CST 2013, time=2013-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951425, encodeId=6604195142582, content=<a href='/topic/show?id=25305234439' target=_blank style='color:#2F92EE;'>#急性痛风#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52344, encryptionId=25305234439, topicName=急性痛风)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Fri Jan 24 19:09:00 CST 2014, time=2014-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062476, encodeId=a68f20624e63e, content=<a href='/topic/show?id=872c15438a4' target=_blank style='color:#2F92EE;'>#Rheumatology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15438, encryptionId=872c15438a4, topicName=Rheumatology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Thu Aug 08 23:09:00 CST 2013, time=2013-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978051, encodeId=5c0319e80511a, content=<a href='/topic/show?id=8c4a168e3bb' target=_blank style='color:#2F92EE;'>#SUA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16873, encryptionId=8c4a168e3bb, topicName=SUA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Wed Jul 03 03:09:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1971079, encodeId=6d9b19e1079cc, content=<a href='/topic/show?id=874929e01cd' target=_blank style='color:#2F92EE;'>#全身炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29701, encryptionId=874929e01cd, topicName=全身炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Sat Sep 07 07:09:00 CST 2013, time=2013-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320800, encodeId=5d5f13208009f, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun May 05 00:09:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516547, encodeId=2642151654ed3, content=<a href='/topic/show?id=3b0329699d3' target=_blank style='color:#2F92EE;'>#全身炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29699, encryptionId=3b0329699d3, topicName=全身炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f6210986148, createdName=12498dd9m14暂无昵称, createdTime=Sun May 05 00:09:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1655031, encodeId=9edb1655031fb, content=<a href='/topic/show?id=7b07e1166af' target=_blank style='color:#2F92EE;'>#痛风发作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71166, encryptionId=7b07e1166af, topicName=痛风发作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfb924615150, createdName=楚秀娟, createdTime=Tue May 21 02:09:00 CST 2013, time=2013-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951425, encodeId=6604195142582, content=<a href='/topic/show?id=25305234439' target=_blank style='color:#2F92EE;'>#急性痛风#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52344, encryptionId=25305234439, topicName=急性痛风)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Fri Jan 24 19:09:00 CST 2014, time=2014-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062476, encodeId=a68f20624e63e, content=<a href='/topic/show?id=872c15438a4' target=_blank style='color:#2F92EE;'>#Rheumatology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15438, encryptionId=872c15438a4, topicName=Rheumatology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Thu Aug 08 23:09:00 CST 2013, time=2013-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978051, encodeId=5c0319e80511a, content=<a href='/topic/show?id=8c4a168e3bb' target=_blank style='color:#2F92EE;'>#SUA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16873, encryptionId=8c4a168e3bb, topicName=SUA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Wed Jul 03 03:09:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1971079, encodeId=6d9b19e1079cc, content=<a href='/topic/show?id=874929e01cd' target=_blank style='color:#2F92EE;'>#全身炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29701, encryptionId=874929e01cd, topicName=全身炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Sat Sep 07 07:09:00 CST 2013, time=2013-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320800, encodeId=5d5f13208009f, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun May 05 00:09:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516547, encodeId=2642151654ed3, content=<a href='/topic/show?id=3b0329699d3' target=_blank style='color:#2F92EE;'>#全身炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29699, encryptionId=3b0329699d3, topicName=全身炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f6210986148, createdName=12498dd9m14暂无昵称, createdTime=Sun May 05 00:09:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1655031, encodeId=9edb1655031fb, content=<a href='/topic/show?id=7b07e1166af' target=_blank style='color:#2F92EE;'>#痛风发作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71166, encryptionId=7b07e1166af, topicName=痛风发作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfb924615150, createdName=楚秀娟, createdTime=Tue May 21 02:09:00 CST 2013, time=2013-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951425, encodeId=6604195142582, content=<a href='/topic/show?id=25305234439' target=_blank style='color:#2F92EE;'>#急性痛风#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52344, encryptionId=25305234439, topicName=急性痛风)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Fri Jan 24 19:09:00 CST 2014, time=2014-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062476, encodeId=a68f20624e63e, content=<a href='/topic/show?id=872c15438a4' target=_blank style='color:#2F92EE;'>#Rheumatology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15438, encryptionId=872c15438a4, topicName=Rheumatology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Thu Aug 08 23:09:00 CST 2013, time=2013-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978051, encodeId=5c0319e80511a, content=<a href='/topic/show?id=8c4a168e3bb' target=_blank style='color:#2F92EE;'>#SUA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16873, encryptionId=8c4a168e3bb, topicName=SUA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Wed Jul 03 03:09:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1971079, encodeId=6d9b19e1079cc, content=<a href='/topic/show?id=874929e01cd' target=_blank style='color:#2F92EE;'>#全身炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29701, encryptionId=874929e01cd, topicName=全身炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Sat Sep 07 07:09:00 CST 2013, time=2013-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320800, encodeId=5d5f13208009f, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun May 05 00:09:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516547, encodeId=2642151654ed3, content=<a href='/topic/show?id=3b0329699d3' target=_blank style='color:#2F92EE;'>#全身炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29699, encryptionId=3b0329699d3, topicName=全身炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f6210986148, createdName=12498dd9m14暂无昵称, createdTime=Sun May 05 00:09:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1655031, encodeId=9edb1655031fb, content=<a href='/topic/show?id=7b07e1166af' target=_blank style='color:#2F92EE;'>#痛风发作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71166, encryptionId=7b07e1166af, topicName=痛风发作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfb924615150, createdName=楚秀娟, createdTime=Tue May 21 02:09:00 CST 2013, time=2013-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951425, encodeId=6604195142582, content=<a href='/topic/show?id=25305234439' target=_blank style='color:#2F92EE;'>#急性痛风#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52344, encryptionId=25305234439, topicName=急性痛风)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Fri Jan 24 19:09:00 CST 2014, time=2014-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062476, encodeId=a68f20624e63e, content=<a href='/topic/show?id=872c15438a4' target=_blank style='color:#2F92EE;'>#Rheumatology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15438, encryptionId=872c15438a4, topicName=Rheumatology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Thu Aug 08 23:09:00 CST 2013, time=2013-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978051, encodeId=5c0319e80511a, content=<a href='/topic/show?id=8c4a168e3bb' target=_blank style='color:#2F92EE;'>#SUA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16873, encryptionId=8c4a168e3bb, topicName=SUA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Wed Jul 03 03:09:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1971079, encodeId=6d9b19e1079cc, content=<a href='/topic/show?id=874929e01cd' target=_blank style='color:#2F92EE;'>#全身炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29701, encryptionId=874929e01cd, topicName=全身炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Sat Sep 07 07:09:00 CST 2013, time=2013-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320800, encodeId=5d5f13208009f, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun May 05 00:09:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516547, encodeId=2642151654ed3, content=<a href='/topic/show?id=3b0329699d3' target=_blank style='color:#2F92EE;'>#全身炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29699, encryptionId=3b0329699d3, topicName=全身炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f6210986148, createdName=12498dd9m14暂无昵称, createdTime=Sun May 05 00:09:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
    2013-07-03 xiongliangxl
  5. [GetPortalCommentsPageByObjectIdResponse(id=1655031, encodeId=9edb1655031fb, content=<a href='/topic/show?id=7b07e1166af' target=_blank style='color:#2F92EE;'>#痛风发作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71166, encryptionId=7b07e1166af, topicName=痛风发作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfb924615150, createdName=楚秀娟, createdTime=Tue May 21 02:09:00 CST 2013, time=2013-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951425, encodeId=6604195142582, content=<a href='/topic/show?id=25305234439' target=_blank style='color:#2F92EE;'>#急性痛风#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52344, encryptionId=25305234439, topicName=急性痛风)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Fri Jan 24 19:09:00 CST 2014, time=2014-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062476, encodeId=a68f20624e63e, content=<a href='/topic/show?id=872c15438a4' target=_blank style='color:#2F92EE;'>#Rheumatology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15438, encryptionId=872c15438a4, topicName=Rheumatology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Thu Aug 08 23:09:00 CST 2013, time=2013-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978051, encodeId=5c0319e80511a, content=<a href='/topic/show?id=8c4a168e3bb' target=_blank style='color:#2F92EE;'>#SUA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16873, encryptionId=8c4a168e3bb, topicName=SUA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Wed Jul 03 03:09:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1971079, encodeId=6d9b19e1079cc, content=<a href='/topic/show?id=874929e01cd' target=_blank style='color:#2F92EE;'>#全身炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29701, encryptionId=874929e01cd, topicName=全身炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Sat Sep 07 07:09:00 CST 2013, time=2013-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320800, encodeId=5d5f13208009f, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun May 05 00:09:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516547, encodeId=2642151654ed3, content=<a href='/topic/show?id=3b0329699d3' target=_blank style='color:#2F92EE;'>#全身炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29699, encryptionId=3b0329699d3, topicName=全身炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f6210986148, createdName=12498dd9m14暂无昵称, createdTime=Sun May 05 00:09:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1655031, encodeId=9edb1655031fb, content=<a href='/topic/show?id=7b07e1166af' target=_blank style='color:#2F92EE;'>#痛风发作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71166, encryptionId=7b07e1166af, topicName=痛风发作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfb924615150, createdName=楚秀娟, createdTime=Tue May 21 02:09:00 CST 2013, time=2013-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951425, encodeId=6604195142582, content=<a href='/topic/show?id=25305234439' target=_blank style='color:#2F92EE;'>#急性痛风#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52344, encryptionId=25305234439, topicName=急性痛风)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Fri Jan 24 19:09:00 CST 2014, time=2014-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062476, encodeId=a68f20624e63e, content=<a href='/topic/show?id=872c15438a4' target=_blank style='color:#2F92EE;'>#Rheumatology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15438, encryptionId=872c15438a4, topicName=Rheumatology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Thu Aug 08 23:09:00 CST 2013, time=2013-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978051, encodeId=5c0319e80511a, content=<a href='/topic/show?id=8c4a168e3bb' target=_blank style='color:#2F92EE;'>#SUA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16873, encryptionId=8c4a168e3bb, topicName=SUA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Wed Jul 03 03:09:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1971079, encodeId=6d9b19e1079cc, content=<a href='/topic/show?id=874929e01cd' target=_blank style='color:#2F92EE;'>#全身炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29701, encryptionId=874929e01cd, topicName=全身炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Sat Sep 07 07:09:00 CST 2013, time=2013-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320800, encodeId=5d5f13208009f, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun May 05 00:09:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516547, encodeId=2642151654ed3, content=<a href='/topic/show?id=3b0329699d3' target=_blank style='color:#2F92EE;'>#全身炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29699, encryptionId=3b0329699d3, topicName=全身炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f6210986148, createdName=12498dd9m14暂无昵称, createdTime=Sun May 05 00:09:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1655031, encodeId=9edb1655031fb, content=<a href='/topic/show?id=7b07e1166af' target=_blank style='color:#2F92EE;'>#痛风发作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71166, encryptionId=7b07e1166af, topicName=痛风发作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfb924615150, createdName=楚秀娟, createdTime=Tue May 21 02:09:00 CST 2013, time=2013-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951425, encodeId=6604195142582, content=<a href='/topic/show?id=25305234439' target=_blank style='color:#2F92EE;'>#急性痛风#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52344, encryptionId=25305234439, topicName=急性痛风)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce68183, createdName=xiongke010, createdTime=Fri Jan 24 19:09:00 CST 2014, time=2014-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062476, encodeId=a68f20624e63e, content=<a href='/topic/show?id=872c15438a4' target=_blank style='color:#2F92EE;'>#Rheumatology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15438, encryptionId=872c15438a4, topicName=Rheumatology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Thu Aug 08 23:09:00 CST 2013, time=2013-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978051, encodeId=5c0319e80511a, content=<a href='/topic/show?id=8c4a168e3bb' target=_blank style='color:#2F92EE;'>#SUA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16873, encryptionId=8c4a168e3bb, topicName=SUA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Wed Jul 03 03:09:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1971079, encodeId=6d9b19e1079cc, content=<a href='/topic/show?id=874929e01cd' target=_blank style='color:#2F92EE;'>#全身炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29701, encryptionId=874929e01cd, topicName=全身炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Sat Sep 07 07:09:00 CST 2013, time=2013-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320800, encodeId=5d5f13208009f, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun May 05 00:09:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516547, encodeId=2642151654ed3, content=<a href='/topic/show?id=3b0329699d3' target=_blank style='color:#2F92EE;'>#全身炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29699, encryptionId=3b0329699d3, topicName=全身炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f6210986148, createdName=12498dd9m14暂无昵称, createdTime=Sun May 05 00:09:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]

相关资讯

AHA2012:治疗急性心肾综合征超滤治疗不如药物治疗

  美国心脏协会(AHA)年会上公布的一项大型多中心随机研究显示,在利尿剂治疗有效的合并心肾综合征的急性失代偿性心力衰竭住院患者中,机械性静脉-静脉超滤的疗效不如药物治疗。   这项急性失代偿性心力衰竭心肾抢救研究(CARRESS-HF)由明尼阿波里斯市亨内平县医疗中心的Bradley A. Bart博士及其同事进行,共纳入188例利尿剂治疗有效的患者。患者被随机分成2组,一组接受阶梯式药物治疗

AHA 2012:治疗急性心肾综合征超滤治疗不如药物治疗

  美国心脏协会(AHA)年会上公布的一项大型多中心随机研究显示,在利尿剂治疗有效的合并心肾综合征的急性失代偿性心力衰竭住院患者中,机械性静脉-静脉超滤的疗效不如药物治疗。   这项急性失代偿性心力衰竭心肾抢救研究(CARRESS-HF)由明尼阿波里斯市亨内平县医疗中心的Bradley A. Bart博士及其同事进行,共纳入188例利尿剂治疗有效的患者。患者被随机分成2组,一组接受阶梯式药物治疗